• Patient reported outcome measures of quality of end-of-life care: a systematic review 

  Kearns, Tara; Cornally, Nicola; Molloy, William (Elsevier Ireland Ltd, 2017)

  End-of-life (EoL) care is increasingly used as a generic term in preference to palliative care or terminal care, particularly with reference to individuals with chronic disease, who are resident in community and long-term ...
• Validation of the 6-Item Cognitive Impairment Test and the 4AT test for combined delirium and dementia screening in older Emergency Department attendees 

  O'Sullivan, Dawn; Brady, Noeleen; Manning, Edmund; O'Shea, Emma; O'Grady, Síle; O'Regan, Niamh; Timmons, Suzanne (Oxford University Press, 2017)

  Background screening for cognitive impairment in Emergency Department (ED) requires short, reliable tools. Objective to validate the 4AT and 6-Item Cognitive Impairment Test (6-CIT) for ED dementia and delirium screening. ...
• Better palliative care for people with a dementia: summary of interdisciplinary workshop highlighting current gaps and recommendations for future research 

  Fox, Siobhán; Fitzgerald, Carol; Dening, Karen Harrison; Irving, Kate; Kernohan, W. George; Treloar, Adrian; Oliver, David; Guerin, Suzanne; Timmons, Suzanne (Biomed Central Ltd, 2017)

  Background: Dementia is the most common neurological disorder worldwide and is a life-limiting condition, but very often is not recognised as such. People with dementia, and their carers, have been shown to have palliative ...
• Advance care planning within survivorship care plans for older cancer survivors: a systematic review 

  O'Caoimh, Rónán; Cornally, Nicola; O'Sullivan, Ronan; Hally, Ruth; Weathers, Elizabeth; Lavan, Amanda H.; Kearns, Tara; Coffey, Alice; McGlade, Ciara; Molloy, D. William (Elsevier, 2017-06-23)

  Advances in the medical treatment of cancer have increased the number of survivors, particularly among older adults, who now represent the majority of these. Survivorship care plans (SCPs) are documents that cancer patients ...
• European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease - The substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow 

  Meulenbroek, Olga; O'Dwyer, Sarah; de Jong, Daan; van Spijker, Gerrita; Kennelly, Sean; Cregg, Fiona; Olde Rikkert, Marcel; Abdullah, Laila; Wallin, Anders; Walsh, Cathal; Coen, Robert; Kenny, Rose Anne; Daly, Leslie; Segurado, Ricardo; Borjesson-Hanson, Anne; Crawford, Fiona; Mullan, Michael; Lucca, Ugo; Banzi, Rita; Pasquier, Florence; Breuilh, Laetitia; Riepe, Matthias; Kalman, Janos; Molloy, D. William; Tsolaki, Magda; Howard, Robert; Adams, Jessica; Gaynor, Siobhan; Lawlor, Brian A. (BMJ Publishing Group, 2016-05-04)

  Introduction: In conjunction with the NILVAD trial, a European Multicentre Double-Blind Placebo Controlled trial of Nilvadipine in Mild-to-Moderate Alzheimer's disease (AD), there are four NILVAD substudies in which eligible ...

View more